Literature DB >> 16966798

Epidemic conjunctivitis in Germany, 2004.

A Schrauder1, D Altmann, G Laude, H Claus, K Wegner, R Köhler, H Habicht-Thomas, G Krause.   

Abstract

Epidemic conjunctivitis can be associated with viral or bacterial pathogens, whereas epidemic keratoconjunctivitis is caused mainly by adenoviruses type 8,19 and 37. In Germany, the incidence of adenovirus conjunctivitis cases increased from 0.2 per 100,000 inhabitants (in 2001 and 2002) eventually to 0.5 in 2003 and 0.8 in 2004. The detection of adenovirus in conjunctival swabs is notifiable to the local health departments. Data about cases with positive conjunctival swabs are then transmitted to the Robert Koch-Institut. Quality control of data takes place and national surveillance data of confirmed cases with adenovirus conjunctivitis are published. From January to April 2004 the national surveillance system captured an outbreak with 1024 cases (131 laboratory confirmed). Analysis of the national surveillance data showed that in March 2004 the group primarily affected by epidemic keratoconjunctivitis was young men between 18-29 years old followed by an increased number of notifications from women in the same age group. Meanwhile the German Armed Forces experienced an outbreak of conjunctivitis, almost exclusively without laboratory confirmation, affecting 6378 soldiers. Despite the small number of laboratory confirmed cases it became clear from the analysis of the national surveillance data that person-to-person transmission between young men and similar age groups of the population did occur. Whether the outbreak started within the garrisons of the German Armed Forces or whether it was triggered within these accommodations, there is clearly a need for the national and the military public health institutions to work together on guidelines to handle future challenges.

Entities:  

Mesh:

Year:  2006        PMID: 16966798

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  8 in total

Review 1.  Epidemic keratoconjunctivitis: the current situation and recommendations for prevention and treatment.

Authors:  Birthe Meyer-Rüsenberg; Ulrike Loderstädt; Gisbert Richard; Paul-Michael Kaulfers; Caroline Gesser
Journal:  Dtsch Arztebl Int       Date:  2011-07-08       Impact factor: 5.594

2.  Amblyopia and strabismus by monocular corneal opacity following suspected epidemic keratoconjunctivitis in infancy.

Authors:  Byoungyoung Gu; Junhyuk Son; Myungmi Kim
Journal:  Korean J Ophthalmol       Date:  2011-07-22

3.  Human adenovirus: Viral pathogen with increasing importance.

Authors:  B Ghebremedhin
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-03-14

4.  Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis.

Authors:  Christian Clement; Joseph A Capriotti; Manish Kumar; Jeffery A Hobden; Timothy P Foster; Partha S Bhattacharjee; Hilary W Thompson; Rashed Mahmud; Bo Liang; James M Hill
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-21       Impact factor: 4.799

5.  SurvNet electronic surveillance system for infectious disease outbreaks, Germany.

Authors:  Gérard Krause; Doris Altmann; Daniel Faensen; Klaudia Porten; Justus Benzler; Thomas Pfoch; Andrea Ammon; Michael H Kramer; Hermann Claus
Journal:  Emerg Infect Dis       Date:  2007-10       Impact factor: 6.883

6.  Virology and epidemiology analyses of global adenovirus-associated conjunctivitis outbreaks, 1953-2013.

Authors:  L Zhang; N Zhao; J Sha; C Wang; X Jin; S Amer; S Liu
Journal:  Epidemiol Infect       Date:  2016-01-06       Impact factor: 4.434

7.  Α molecular epidemiological analysis of adenoviruses from excess conjunctivitis cases.

Authors:  A Balasopoulou; P Κokkinos; D Pagoulatos; P Plotas; O E Makri; C D Georgakopoulos; A Vantarakis
Journal:  BMC Ophthalmol       Date:  2017-04-24       Impact factor: 2.209

8.  Adenovirus-associated acute conjunctivitis in Beijing, China, 2011-2013.

Authors:  Jie Li; Xiaoyan Lu; Baoming Jiang; Yiwei Du; Yang Yang; Haikun Qian; Baiwei Liu; Changying Lin; Lei Jia; Lijuan Chen; Quanyi Wang
Journal:  BMC Infect Dis       Date:  2018-03-20       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.